ICON Public Limited Company (ICLR)

Market Cap	11.73B
Revenue (ttm)	8.19B
Net Income (ttm)	758.19M
Shares Out	79.46M
EPS (ttm)	9.19
PE Ratio	16.06
Forward PE	10.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,120,547
Open	150.24
Previous Close	150.10
Day's Range	146.56 - 150.24
52-Week Range	125.10 - 347.72
Beta	1.18
Analysts	Buy
Price Target	204.18 (+38.34%)
Earnings Date	Jul 23, 2025

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,900
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR
• Website: https://www.iconplc.com

Financial Performance

In 2024, ICLR's revenue was $8.28 billion, an increase of 1.99% compared to the previous year's $8.12 billion. Earnings were $791.47 million, an increase of 29.26%.

Analyst Summary

According to 12 analysts, the average rating for ICLR stock is "Buy." The 12-month stock price target is $204.18, which is an increase of 38.34% from the latest price.

Price Target

$204.18

(38.34% upside)

Analyst Consensus: Buy